摩根基金-基因治療主題基金- JPM 基因治療主題(美元) - A股(累計)
113.54美元0.19(0.17%)
2023/02/06更新
績效 / 1月7.02%
3月2.83%
1年9.98%
晨星評等-
- 1.現金0.60%
- 2.股票28.84%
- 3.債券0.00%
- 4.其他70.56%
- 1.美國70.57%
- 2.歐洲不包含歐元區9.92%
- 3.日本7.43%
- 4.歐元區5.31%
- 5.新興亞洲2.13%
- 1.Sarepta Therapeutics Inc3.66%
- 2.Alnylam Pharmaceuticals Inc3.60%
- 3.Gilead Sciences Inc3.52%
- 4.Novartis AG3.31%
- 5.Biogen Inc3.29%
- 6.Biomarin Pharmaceutical Inc3.23%
- 7.Vertex Pharmaceuticals Inc3.19%
- 8.Amgen Inc3.19%
- 9.Astellas Pharma Inc3.15%
- 10.Roche Holding AG2.94%
- 1.現金0.60%
- 2.股票28.84%
- 3.債券0.00%
- 4.其他70.56%
- 1.美國70.57%
- 2.歐洲不包含歐元區9.92%
- 3.日本7.43%
- 4.歐元區5.31%
- 5.新興亞洲2.13%
- 1.Sarepta Therapeutics Inc3.66%
- 2.Alnylam Pharmaceuticals Inc3.60%
- 3.Gilead Sciences Inc3.52%
- 4.Novartis AG3.31%
- 5.Biogen Inc3.29%
- 6.Biomarin Pharmaceutical Inc3.23%
- 7.Vertex Pharmaceuticals Inc3.19%
- 8.Amgen Inc3.19%
- 9.Astellas Pharma Inc3.15%
- 10.Roche Holding AG2.94%